GLP-1 vs Qsymia: Comparing Two Prescription Weight Loss Options

If you're exploring prescription weight loss options, you've likely come across both GLP-1 medications and Qsymia. These two approaches work in fundamentally different ways, and choosing between them depends on your health history, goals, and how your body responds to treatment. Let's break down what makes each option unique so you can have a more informed conversation with your healthcare provider.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that mimic a hormone your body naturally produces after eating. This hormone, glucagon-like peptide-1, helps regulate blood sugar and appetite.

The most commonly prescribed GLP-1 medications for weight loss include semaglutide and tirzepatide. Originally developed for type 2 diabetes, these medications have proven remarkably effective for weight management.

How GLP-1 Medications Work

GLP-1s work through several mechanisms. They slow down how quickly food leaves your stomach, which helps you feel full longer. They also act on appetite centers in your brain to reduce hunger signals and food cravings.

Additionally, these medications help regulate blood sugar levels by stimulating insulin release when glucose is elevated and reducing glucagon secretion. This dual action makes them particularly beneficial for people with prediabetes or type 2 diabetes alongside excess weight.

What Is Qsymia?

Qsymia is a combination medication containing two active ingredients: phentermine and topiramate extended-release. It's been FDA-approved for chronic weight management since 2012.

Phentermine is a stimulant that suppresses appetite, while topiramate is an anticonvulsant that also reduces appetite and may help you feel full sooner when eating.

How Qsymia Works

Qsymia works primarily by suppressing appetite through your central nervous system. The phentermine component acts as an appetite suppressant, while topiramate contributes additional appetite control and may influence taste perception, making some foods less appealing.

Unlike GLP-1 medications, Qsymia doesn't directly affect how your body processes sugar or slow stomach emptying. Its mechanism is more focused on reducing hunger signals in your brain.

Effectiveness: What the Research Shows

Both medication types have demonstrated meaningful weight loss in clinical trials, though results vary between individuals.

GLP-1 medications have shown particularly impressive results in recent studies. Semaglutide trials showed participants losing an average of 15-20% of their body weight over 68 weeks. Tirzepatide demonstrated even higher average weight loss of 15-22% depending on the dose.

Qsymia clinical trials showed participants losing an average of 7-10% of their body weight over one year, with higher doses producing greater results.

It's important to remember these are averages. Individual results depend on many factors including starting weight, diet, exercise, medication adherence, and metabolic factors.

Side Effects and Considerations

Common GLP-1 Side Effects

The most common side effects with GLP-1 medications are gastrointestinal. These include nausea, vomiting, diarrhea, and constipation. Most people find these effects are mild to moderate and improve over time as their body adjusts.

Starting with a low dose and gradually increasing helps minimize these effects. Eating smaller meals and avoiding high-fat foods can also help.

Common Qsymia Side Effects

Qsymia's side effects differ due to its stimulant component. Common effects include tingling in hands and feet, dizziness, altered taste, insomnia, dry mouth, and constipation.

Because it contains a stimulant, Qsymia can increase heart rate and isn't appropriate for people with certain heart conditions or uncontrolled high blood pressure. It's also not suitable during pregnancy and requires pregnancy prevention due to the risk of birth defects.

Administration Differences

GLP-1 medications are administered as weekly injections using a small, pre-filled pen with a tiny needle. Most people find the injections easy and relatively painless after the first few times.

Qsymia is taken as a daily oral capsule, which some people prefer over injections. However, daily adherence is required for effectiveness.

Gender-Specific Considerations

Both medications work effectively in men and women, though there are some specific considerations to keep in mind.

For women of childbearing age, Qsymia requires more stringent pregnancy prevention measures due to the risk of birth defects from topiramate. A pregnancy test is required before starting and monthly during treatment.

Women may experience more pronounced gastrointestinal side effects with GLP-1 medications, though this varies individually. Some research suggests women may achieve slightly better weight loss results with GLP-1s compared to men, though both genders see significant benefits.

Men using Qsymia may be more prone to experiencing increased heart rate, making cardiovascular monitoring particularly important.

Cost and Accessibility

Cost can be a significant factor when choosing between these options. Brand-name GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound can be expensive without insurance coverage, often exceeding $1,000 per month.

Compounded semaglutide and tirzepatide offer more affordable alternatives, typically ranging from $99 to several hundred dollars monthly depending on the provider and dose.

Qsymia's cost varies with insurance but generally ranges from $150-$200 monthly without coverage. Some insurance plans cover it more readily than GLP-1 medications for weight loss.

Which Option Might Be Right for You?

The choice between GLP-1 medications and Qsymia depends on your individual health profile, preferences, and treatment goals.

GLP-1 medications may be particularly appropriate if you have prediabetes or type 2 diabetes, prefer weekly administration over daily pills, or want the additional metabolic benefits these medications provide.

Qsymia might be worth considering if you prefer oral medication, have had difficulty with GLP-1 side effects in the past, or have insurance coverage that makes it more affordable.

Some people aren't good candidates for Qsymia, including those with glaucoma, hyperthyroidism, recent history of cardiovascular disease, or those who are pregnant or planning pregnancy.

Your healthcare provider can help assess which option aligns best with your medical history, current health status, and weight loss goals.

From the Ozari Care Team

Whichever medication you choose, success comes from consistency and lifestyle integration. We find our patients have the best outcomes when they view medication as one tool supporting sustainable nutrition and movement habits, not a standalone solution. Remember that gradual, steady progress is more sustainable than rapid changes.

Ready to Explore Your Options?

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026